Portefeuille d'ETF LABU (NYSE) - Page 3 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

NBIX Neurocrine Biosciences Inc 3.4 M 24.8 K 0.6%

CRSP CRISPR Therapeutics AG 3.3 M 67.0 K 0.6%

ADMA Adma Biologics Inc 3.3 M 193.2 K 0.6%

ACAD Acadia Pharmaceuticals Inc 3.3 M 131.5 K 0.6%

BEAM Beam Therapeutics Inc. 3.2 M 117.3 K 0.6%

ALNY Alnylam Pharmaceuticals Inc. 3.2 M 9 543.0 0.6%

INSM Insmed Inc 3.2 M 20.3 K 0.6%

A

ACLX Arcellx Inc 3.2 M 46.1 K 0.5%

NUVL Nuvalent Inc 3.1 M 30.5 K 0.5%

TWST Twist Bioscience Corporation 3.1 M 75.8 K 0.5%

VKTX Viking Therapeutics Inc. 3.0 M 102.8 K 0.5%

ARQT Arcutis Biotherapeutics Inc. 2.9 M 114.1 K 0.5%

KYMR Kymera Therapeutics Inc 2.8 M 38.9 K 0.5%

DYN Dyne Therapeutics Inc. 2.8 M 155.1 K 0.5%

SMMT Summit Therapeutics Inc. 2.8 M 190.9 K 0.5%

DNLI Denali Therapeutics Inc 2.8 M 127.1 K 0.5%

IDYA IDEAYA Biosciences Inc. 2.7 M 83.8 K 0.5%

RXRX Recursion Pharmaceuticals Inc 2.7 M 642.7 K 0.5%

COGT Cogent Biosciences Inc. 2.6 M 73.7 K 0.5%

SRPT Sarepta Therapeutics Inc 2.6 M 129.5 K 0.5%

1
2
3
4
5
6
7
8

Nouvelles

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies

Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors